Myolex, Inc.

Myolex develops a portable, non-invasive device called EIM (Electrical Impedance Myography) that measures muscle composition and structure to assess neuromuscular and musculoskeletal diseases such as ALS and muscular dystrophy. The device uses painless electrical current to quantify muscle quality in seconds and can be used at home or in clinical settings for diagnosis, monitoring, and drug development.